Systemtherapie des metastasierten Tumors des oberen HarntraktesSystemic treatment of metastatic tumors of the upper urinary tract

被引：0
|
作者：
C. Darr
B. A. Hadaschik
S. Tschirdewahn
机构：
[1] Universitätsmedizin Essen,Klinik und Poliklinik für Urologie, Kinderurologie und Uroonkologie
来源：
Der Urologe | 2019年 / 58卷 / 1期
关键词：
Urothelkarzinom; Chemotherapie; Immuntherapie; Harnblasenkarzinom; Gemcitabin; Urothelial carcinoma; Chemotherapy; Immunotherapy; Bladder cancer; Gemcitabin;
D O I：
10.1007/s00120-018-0835-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：30 / 33
页数：3
相关论文
共 50 条
  • [31] Three-port retroperitoneal laparoscopic complete nephroureterectomy with bladder-cuff resection for treatment of upper urinary tract malignant tumors
    Zhang, Bao
    Gao, Qiang
    Shi, Yuqiang
    Lei, Zhentao
    Yang, Lin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (03): : 2760 - 2766
  • [32] Moderne Konzepte der Systemtherapie zur adjuvanten und palliativen Behandlung des lokal fortgeschrittenen oder metastasierten ÖsophaguskarzinomsModern concepts of systemic treatment for adjuvant and palliative treatment of locally advanced or metastasized esophageal cancer
    Sylvie Lorenzen
    Anke Reinacher-Schick
    Michael Masetti
    Der Chirurg, 2021, 92 (12): : 1085 - 1093
  • [33] The Effect of Tumor Localization and Clinicopathological Factors on Intravesical Recurrence and Survival in Primary Upper Urinary Tract Urothelial Tumors
    Izol, Volkan
    Kizilgok, Bahattin
    Degar, Mutlu
    Bayazit, Yildirim
    Tansug, Mustafa Zuhtu
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2020, 19 (02): : 85 - 91
  • [34] Drug-eluting biodegradable ureteral stent: New approach for urothelial tumors of upper urinary tract cancer
    Barros, Alexandre A.
    Browne, Shane
    Oliveira, Carlos
    Lima, Estevao
    Duarte, Ana Rita C.
    Healy, Kevin E.
    Reis, Rui L.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 513 (1-2) : 227 - 237
  • [35] Urothelkarzinom des oberen und unteren Harntrakts – welche Risikofaktoren machen Früherkennungsmaßnahmen sinnvoll?Urothelial carcinoma of the upper and lower urinary tract—which risk factors make early detection worthwhile?
    Niklas Westhoff
    Constantin Rieger
    Axel Heidenreich
    Christian Bolenz
    Maurice Stephan Michel
    Die Urologie, 2025, 64 (1) : 4 - 13
  • [36] Therapie des metastasierten Prostatakarzinoms im Wandel – neue Daten und offene FragenChanges in the treatment of metastatic prostate cancer—new data and open questions
    P. Albers
    M. Bögemann
    S. Machtens
    A. S. Merseburger
    M. Schostak
    T. Steuber
    C. Wülfing
    M. De Santis
    Der Urologe, 2020, 59 (3): : 307 - 317
  • [37] Large series of 114 cases with long-term follow-up of upper urinary tract urothelial tumors
    Izquierdo, L.
    Truan, D.
    Alvarez-Vijande, R.
    Alcaraz, A.
    ACTAS UROLOGICAS ESPANOLAS, 2010, 34 (03): : 232 - 237
  • [38] DWI in the Etiologic Diagnosis of Excretory Upper Urinary Tract Lesions: Can It Help in Differentiating Benign From Malignant Tumors? A Retrospective Study of 98 Patients
    Roy, Catherine
    Labani, Aissam
    Alemann, Guillaume
    Bierry, Guillaume
    Lang, Herve
    Ohana, Mickael
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2016, 207 (01) : 106 - 113
  • [39] Local Endoscopic Treatment of Low-Grade Urothelial Tumors in the Upper Urinary Tract-Oncological Outcome of a Consecutive Single-Center Series of 118 Patients
    Bislev, Sophie
    Brandt, Simone Buchardt
    Fuglsig, Sven
    Jensen, Jorgen Bjerggaard
    CANCERS, 2024, 16 (22)
  • [40] Treatment of metastatic renal cell carcinoma. Immunotherapy versus surgical removal [Behandlung des metastasierten nierenzellkarzinoms. Stellenwert der immuntherapie gegenuber der metastasenchirurgie]
    Heinzer H.
    Huland E.
    Huland H.
    Der Urologe A, 2000, 39 (4): : 356 - 361
12345